These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26833006)

  • 41. [An analysis of factors associated with timeliness of antiretroviral therapy initiation among newly diagnosed HIV/AIDS from 2010 to 2014 in China].
    Tang HL; Xu J; Han J; Li J; Mao YR
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Aug; 51(8):711-717. PubMed ID: 28763920
    [No Abstract]   [Full Text] [Related]  

  • 42. [Survival analysis on AIDS antiretroviral therapy in Henan province during 2003-2009].
    Sun DY; Wang Q; Yang WJ; Zhu Q; Wang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Feb; 33(2):181-4. PubMed ID: 22575139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Studies on the determinants and changes related to the natural CD4(+) T cell counts among antiretroviral treatment-naive HIV/AIDS patients in Dehong prefecture, Yunnan province].
    Ye RH; Duan S; Xiang LF; Yang YC; Yang ZJ; Han WX; Cao DD; Yang JH; Li WM; Yang J; Wang JB; Gao J; Gong YR; Yang SJ; Zhu P; He N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Sep; 32(9):882-7. PubMed ID: 22340875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [AIDS and injecting drug use: survival determinants in the highly active antiretroviral therapy era].
    Zucchetto A; Bruzzone S; De Paoli A; Regine V; Pappagallo M; Dal Maso L; Serraino D; Rezza G; Suligoi B
    Epidemiol Prev; 2009; 33(4-5):184-9. PubMed ID: 20124634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Survival analysis since diagnosis of HIV-positive injecting drug users aged 15 years and above in China].
    Jin YC; Cai C; Chen FF; Qin QQ; Tang HL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Jun; 43(6):860-864. PubMed ID: 35725342
    [No Abstract]   [Full Text] [Related]  

  • 46. Correlation between negative life events and suicide attempts among Yi adolescents with HIV/AIDS in Liangshan Prefecture.
    Song X; Zou S; Li Y; Chen L; Feng P; Xu P; Zhang H; Deng F; Xu H; Tao Y; Jin M; Ran M; Zhang H; Ma F; Wang Y; Yin L
    BMC Public Health; 2023 Aug; 23(1):1600. PubMed ID: 37608310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Survival analysis of people living with HIV/AIDS in Sichuan province, 1991-2017].
    Zeng YL; Tang HL; Li JM; Wang QS; Yu H; Su L; Yang W; Gong Y; Li T; Huang WL; Zhang LL; Lai WW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Mar; 40(3):309-314. PubMed ID: 30884609
    [No Abstract]   [Full Text] [Related]  

  • 48. Survival Analysis of Antiretroviral Treatment for PLWH in Sichuan Province, China, 2003-2022: A Large Retrospective Cohort Study.
    Ye L; Sun X; Li Y; Zeng Y; Zhuoma L; Zhou D; He Q; Wang J; Yang W; Yu H; Yang Y; Liang S; Yuan D
    Infect Drug Resist; 2024; 17():3133-3143. PubMed ID: 39050836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of factors associated with antiretroviral therapy intiation and its timeliness among HIV sero-discordant couples in high HIV prevalence regions, China].
    Li J; Mao Y; Tang H; Han J; Xu J; Wu Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Jul; 49(7):625-31. PubMed ID: 26310476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiretroviral therapy in AIDS patients with CMV disease: impact on the survival and long-term treatment outcome.
    Sungkanuparph S; Chakriyanuyok T; Butthum B
    J Infect; 2008 Jan; 56(1):40-3. PubMed ID: 18037166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival analysis of PLWHA undergoing combined antiretroviral therapy: exploring long-term prognosis and influencing factors.
    Pu JF; Wu J
    Front Public Health; 2024; 12():1327264. PubMed ID: 38454987
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [HIV/AIDS related mortality in southern Shanxi province and its risk factors].
    Ning S; Xue Z; Wei J; Mu S; Xu Y; Jia S; Qiu C; Xu J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Mar; 36(3):245-9. PubMed ID: 25975402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Associated factors for progression to AIDS among HIV-infected people who use drugs: a retrospective cohort study in Dongguan, China.
    Luo H; Sun M; Du J
    BMJ Open; 2019 Jul; 9(7):e023841. PubMed ID: 31272970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Influencing factors of antiretroviral therapy and its association with immunological effect among HIV/AIDS patients in Taizhou city, 2006-2019].
    He JY; Wang SL; Xu YY; Shen WW; Ding YY; Lin HJ; He N; Chen XX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2093-2097. PubMed ID: 33378822
    [No Abstract]   [Full Text] [Related]  

  • 55. [A retrospective cohort study on reduction of AIDS mortality among patients enrolled in national-free antiretroviral treatment programme in two cities in China].
    Dou ZH; Zhao Y; He Y; He WS; Ji GP; Xu C; Ma Y; Zhao DC; Yu L; Zhang FJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Dec; 43(12):1091-5. PubMed ID: 20193506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Analysis on death trend in AIDS patients and related risk factors in China].
    Cai C; Tang HL; Li DM; Lyu P
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jan; 42(1):121-125. PubMed ID: 33503707
    [No Abstract]   [Full Text] [Related]  

  • 57. [Incidence and influencing factors of AIDS-related and non-AIDS-related deaths after receiving antiretroviral therapy among HIV-positive individuals in Dehong Dai and Jingpo Autonomous Prefecture, 2010-2019].
    Yao ST; He CY; Cao DD; Zhang YD; Shi Y; Li PY; Feng YL; Wei H; Xiao GF; Sun JT; Ye RH; Yang YC; Wang JB; He N; Ding YY; Duan S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Apr; 42(4):632-637. PubMed ID: 34814442
    [No Abstract]   [Full Text] [Related]  

  • 58. Trends in HIV/AIDS-Related Mortality and the Impact of Antiretroviral Treatment Strategies in Lu'an City: A Comprehensive Analysis.
    Shu R; Lyu H; Ma G; Chen H; Zhou Y; Zhou J; Chen J; Wang Q
    Med Sci Monit; 2024 Jul; 30():e944727. PubMed ID: 39042588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictive factors of viral load high-risk events for virological failure in HIV/AIDS patients receiving long-term antiviral therapy.
    Qin S; Lai J; Zhang H; Wei D; Lv Q; Pan X; Huang L; Lan K; Meng Z; Liang H; Ning C
    BMC Infect Dis; 2021 May; 21(1):448. PubMed ID: 34006230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survival Trend of HIV/AIDS Patients Starting Antiretroviral Therapy in South Korea between 2001 and 2015.
    Kim YC; Ahn JY; Kim HY; Song JY; Park DW; Kim MJ; Choi HJ; Kim SW; Kee MK; Han MG; Yoo M; Kim SM; Choi Y; Choi BY; Kim SI; Choi JY
    Yonsei Med J; 2020 Aug; 61(8):705-711. PubMed ID: 32734734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.